Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. (Q50792279)

19 March 2018

title

Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. (English)

1 reference

19 March 2018

0 references

7

Shyamala Maheswaran

1 reference

19 March 2018

author name string

Hirofumi Kawakubo

1

1 reference

19 March 2018

Jennifer L Carey

2

1 reference

19 March 2018

Elena Brachtel

3

1 reference

19 March 2018

Vandana Gupta

4

1 reference

19 March 2018

Jeffrey E Green

5

1 reference

19 March 2018

Paul D Walden

6

1 reference

19 March 2018

language of work or name

English

0 references

publication date

1 October 2004

1 reference

19 March 2018

published in

Oncogene

1 reference

19 March 2018

volume

23

1 reference

19 March 2018

issue

50

1 reference

19 March 2018

page(s)

8310-8319

1 reference

19 March 2018

Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Loss of heterozygosity on chromosome 1q in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Initiating oncogenic event determines gene-expression patterns of human breast cancer models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Enzymatic methylation of recombinant TIS21 protein-arginine residues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Expression of B-cell translocation gene 2 protein in normal human tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208008

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208008

1 reference

19 March 2018

1 reference

19 March 2018